1. Home >
  2. M&A >
  3. Stake Purchase >
  4. Germany >
  5. Maruho Co. Invests In Biofrontera

Stake Purchase • Life Science

Maruho Co. Invests In Biofrontera

On April 1, 2013, Maruho Co. invested in life science company Biofrontera

Investment Context
  • This is Maruho Co.’s 2nd transaction in the Life Science sector.
  • This is Maruho Co.’s 1st transaction in Germany.

Explore All 282 Stake Purchase Life Science Deals - Search the Database Free


Investment Summary
Date April 1, 2013
Target Biofrontera
Sector Life Science
Investor(s) Maruho Co.
Deal Type Stake Purchase

Target Company

Biofrontera

Leverkusen, Germany
Biofrontera is a biopharmaceutical company specializing in dermatological drugs and medical cosmetics. The company develops and markets innovative products that heal, protect, and care for the skin. Its products include Ameluz, a prescription medication that is used to treat non-melanoma skin cancer and its preliminary stages. Biofrontera was founded in 1997 and is based in Leverkusen, Germany.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Maruho Co.

Osaka, Japan
Category Company
Founded 1915
Sector Medical Products
DESCRIPTION

Maruho Co., Ltd. is a provider of innovative pharmaceutical products to treat a variety of skin diseases in the global market place.

Deal Context for Investor #
Overall 2 of 2
Sector: Life Science 2 of 2
Type: Stake Purchase 1 of 1
Country: Germany 1 of 1
Year: 2013 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-02-13 Cutanea Life Sciences

Wayne, Pennsylvania, United States

Cutanea Life Sciences is a pharmaceutical company specializing in novel patent-protected pharmaceuticals to treat skin diseases.

Buy -

Explore Related M&A Activity

Life Science M&A - Stake Purchase M&A Deals - Germany M&A - 2013 M&A

Mergr

Solution for

Product

Company

Legal